Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
NCT05748613
This study is recruiting at 3 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to test the effectiveness of a computerized anxiety sensitivity treatment (CAST) compared to a health education control (HEC) in older adults with mild cognitive impairment (MCI) or mild Alzheimer's Disease and related dementias (ADRD) and their care partners.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Anxiety
- Mild Cognitive Impairment
- Alzheimer Disease
- Dementia
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Florida State University
- Last updated on ClinicalTrials.gov
- March 5, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Anxiety and Behavioral Health Clinic · Tallahassee, FL
Ohio · 2
- Ohio University · Athens, OH
- The Ohio State University · Columbus, OH
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.